28567-37-5

Usage

Uses

Used in Organic Synthesis:
Triphenylmethyl ether is used as a protecting group for hydroxyl groups in organic synthesis to prevent unwanted reactions, ensuring the selective formation of desired products.
Used in Pharmaceutical Synthesis:
It serves as a precursor in the synthesis of pharmaceuticals, contributing to the development of new drugs and medicinal compounds.
Used in Energy Storage:
Triphenylmethyl ether is studied for its potential as a solid-state electrolyte in lithium-ion batteries, due to its high ionic conductivity and stability, which could enhance the performance and safety of these batteries. However, further research is required to fully understand and optimize its properties for this application.

Upstream product

• 76-83-5 trityl chloride 
• 119291-44-0 carbonic acid ditrityl ester 
• 71-43-2 benzene 
• 91-01-0 1,1-Diphenylmethanol 
• 76-84-6 triphenylmethyl alcohol 

Downstream Products

• 15218-61-8 {(C₆H₅)3C}⁽¹⁺⁾*{(C₆H₅)3CO(BF₂CH₂)2}^(1-)=(C₆H₅)3C(C₆H₅)3CO(BF₂CH₂)2 
• 15218-62-9 {C(C₆H₅)3}⁽¹⁺⁾*{CH₃OB₂F₄C₂H₄}^(1-) 

Relevant academic research and scientific papers

Antiviral phosphonate nucleotides

The present invention relates to a novel nucleotide analogue having the general formula (I) and pharmaceutically acceptable salts, esters, or salt of such esters: wherein n, X, Q U R1′, R1, Z and R2are defined here within. The compounds object

Epothilone analogs

Epothilone A, epothilone B, analogs of epothilone and libraries of epothilone analogs are synthesized. Epothilone A and B are known anticancer agents that derive their anticancer activity by the prevention of mitosis through the induction and stabilization of microtubulin assembly. The analogs of epothilone are novel. Several of the anlogs are demonstrated to have a superior cytotoxic activities as compared to epothilone A or epothilone B as demonstrated by their enhanced ability to induce the polymerization and stabilization of microtubules.

Process for the preparation of the (R) stereoisomer of the monobutyric ester of 2,2-bis(hydroxymethyl)-tetrahydrofuran, its use in preparing stereoisomers of pharmacologically active compounds, and certain specific stereoisomers produced thereby

A process for preparing the (R) stereoisomer of 2,2-bis(hydroxmethyl)-tetrahydrofuran monobutyrate comprising subjecting the dibutyric ester of the 2,2-bis(hydroxymethyl)-tetrahydrofuran to enzymatic hydrolysis. The invention also relates to the novel (R)

Process for carbapenem intermediates

A novel intermediate for synthesizing 1 β-alkyl-1-carbapenem, i.e., 4 β-(1 β-alkyl-2-carboxyprop-2-enyl)azetidin-2-one (II), is prepared stereoselectively by treating 4-(leaving group substituted)azetidin-2-one (I) with trans-2-(leaving group substituted)-methyl-3-alkylacrylic acid (III) and a reducing metal. STR1 wherein R1 is hydrogen, alkyl, or substituted alkyl; R2 is optionally substituted alkyl; R3 is hydrogen or a carboxy-protecting group; and R4 and R5 each is a leaving group.

Novel polysaccharides novel macromolecular conjugates of the polysaccharides

Synthesis of oligomeric subunits of the poly(ribosyl-ribitol-phosphate) capsular polysaccharide found on Haemophilus influenzaetype b bacteria. The covalent attachment of these compounds to immunogenic proteins without using spacer elements.

Transformation of Carbinols by RuCl2(PPh3)3 and by Some Other Transition-Metal Catalysts

Several platinoid metal catalysts have been shown to promote reductive coupling, dehydration, disproportionation, and dehydrogenation of diarylcarbinols.Mechanistic studies were performed at 180-210 deg C with benzhydrol as substrate and RuCl2(PPh3)3 as catalyst.In aromatic hydrocarbon solvents the main process is reductive coupling.In this medium solvated RuCl2(PPh3)2 is suggested to be the active catalyst.In dimethyl sulfoxide the starting complex is transformed initially into RuCl2(PPh3)(Me2SO)2 and causes chiefly carbinol dehydrogenation.Ruthenium alkoxides are implied as common reaction intermediates in all four catalyses.Ruthenium hydrides are suggested to take part in the reductive coupling, disproportionation, and dehydrogenation processes.Some aliphatic and primary aromatic alcohols that do not react by themselves in the presence of RuCl2(PPh3)3 can both serve as active hydrogen donors and form crossover products in the presence of secondary and tertiary aromatic carbinols.

Preparation of novel keto-esters

Novel keto-esters which are represented by the general formula STR1 wherein R1 represents methyl or benzyl, and X represents hydroxy, trityloxy, tosyloxy or halogen, and process for the preparation of said keto-esters.